Literature DB >> 15286397

Rodent models of experimental autoimmune uveitis.

Rajeev K Agarwal1, Rachel R Caspi.   

Abstract

The model of experimental autoimmune uveitis (EAU) in mice and in rats is described. EAU targets immunologically privileged retinal antigens and serves as a model of autoimmune uveitis in humans as well as a model for autoimmunity in a more general sense. EAU is a well-characterized, robust, and reproducible model that is easily followed and quantitated. It is inducible with synthetic peptides derived from retinal autoantigens in commonly available strains of rats and mice. The ability to induce EAU in various gene-manipulated, including HLA-transgenic, mouse strains makes the EAU model suitable for the study of basic mechanisms as well as in clinically relevant interventions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15286397     DOI: 10.1385/1-59259-805-6:395

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  49 in total

1.  Myeloid suppressor cells induced by retinal pigment epithelial cells inhibit autoreactive T-cell responses that lead to experimental autoimmune uveitis.

Authors:  Zhidan Tu; Yan Li; Dawn Smith; Catherine Doller; Sunao Sugita; Chi-Chao Chan; Shiguang Qian; John Fung; Rachel R Caspi; Lina Lu; Feng Lin
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-23       Impact factor: 4.799

2.  IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses.

Authors:  Reiko Horai; Mary J Mattapallil; Wai Po Chong; Phyllis B Silver; Jun Chen; Ru Zhou; Yuri Sergeev; Rafael Villasmil; Chi-Chao Chan; Rachel R Caspi
Journal:  J Autoimmun       Date:  2013-09-07       Impact factor: 7.094

Review 3.  Emerging role of antioxidants in the protection of uveitis complications.

Authors:  U C S Yadav; N M Kalariya; K V Ramana
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

4.  Diverse roles of natural killer T lymphocytes in liver and spleen in mice with experimental autoimmune uveitis.

Authors:  Shengya Zhao; Dadong Guo; Hongsheng Bi; Yan Cui; Xiaofeng Xie; Xingrong Wang; Jiao Li
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

5.  Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties.

Authors:  Erin A Kimbrel; Nicholas A Kouris; Gregory J Yavanian; Jianlin Chu; Yu Qin; Ann Chan; Ram P Singh; Deborah McCurdy; Lynn Gordon; Ralph D Levinson; Robert Lanza
Journal:  Stem Cells Dev       Date:  2014-05-02       Impact factor: 3.272

6.  Characterization of microRNA expression profiling in peripheral blood lymphocytes in rats with experimental autoimmune uveitis.

Authors:  Dadong Guo; Jiao Li; Zhengfeng Liu; Kai Tang; Huixin Song; Hongsheng Bi
Journal:  Inflamm Res       Date:  2015-07-08       Impact factor: 4.575

7.  Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses.

Authors:  Rafael S Grajewski; Anna M Hansen; Rajeev K Agarwal; Mitchell Kronenberg; Stephane Sidobre; Shao Bo Su; Phyllis B Silver; Moriya Tsuji; Richard W Franck; Anne P Lawton; Chi-Chao Chan; Rachel R Caspi
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

8.  Effects of Japanese herbal medicine Sairei-to on murine experimental autoimmune uveitis.

Authors:  Toshikatsu Kaburaki; Qi Zhang; Xiangyuan Jin; Masateru Uchiyama; Yujiro Fujino; Hisae Nakahara; Mitsuko Takamoto; Kazuyoshi Otomo; Masanori Niimi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-15       Impact factor: 3.117

Review 9.  Mitochondrial oxidative stress initiates visual loss in sympathetic ophthalmia.

Authors:  Yutaka Kaneko; Narsing A Rao
Journal:  Jpn J Ophthalmol       Date:  2012-04-03       Impact factor: 2.447

10.  Role of DAF in protecting against T-cell autoreactivity that leads to experimental autoimmune uveitis.

Authors:  Fengqi An; Qing Li; Zhidan Tu; Hong Bu; Chi-Chao Chan; Rachel R Caspi; Feng Lin
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-14       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.